Search
for

    Sort by

    Research 241–270 of 1000+

    1. The effective course of finasteride pretreatment in decreasing blood loss associated with TURP Journal of Clinical Urology · 2005
    2. Effects of 5-?±-Reductase Inhibitor (Finasteride) on Per Operative Blood Loss in Patients with BPH undergoing TURP International Journal of Medical Research and Health Sciences · 2018
    3. MP13-07 FINASTERIDE MONOTHERAPY BEFORE TURP: SIGNIFICANT IMPROVEMENT IN EARLY POSTOPERATIVE QUALITY OF LIFE The Journal of Urology · 2017
    4. Is sulfonamide group of tamsulosin main factor in the pathophysiology of floppy iris syndrome? Haydarpaşa Numune Hastanesi tıp dergisi · 2018
    5. Pharmacological Effects of the Lipidosterolic Extract from Kigelia africana Fruits in Experimental Benign Prostatic Hyperplasia Induced by Testosterone in Sprague Dawley Rats Journal of Experimental Pharmacology · 2023 · 3 citations
    6. UTILIZAÇÃO DE FINASTERIDA NO TRATAMENTO DA HIPERPLASIA PROSTÁTICA BENIGNA – RELATO DE CASO Enciclopédia Biosfera · 2023
    7. Dutasteride: a guide to its use as monotherapy in benign prostatic hyperplasia Drugs & therapy perspectives · 2008
    8. Current evidence for the involvement of sex steroid receptors and sex hormones in benign prostatic hyperplasia Research and Reports in Urology · 2019 · 26 citations
    9. Effect of Citrullus colocynthis Schard on Testosterone-Induced Benign Prostatic Hyperplasia Journal of Complementary and Integrative Medicine · 2009 · 5 citations
    10. Association of Benign Prostatic Hyperplasia with Male Pattern Baldness Urology · 1998 · 54 citations
    11. α-spinasterol from Melandrium firmum attenuates benign prostatic hyperplasia in a rat model Molecular Medicine Reports · 2014 · 15 citations
    12. Androgenic Alopecia Is Associated With More Severe Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia LUTS Lower Urinary Tract Symptoms · 2024
    13. Hormonal manipulation of benign prostatic hyperplasia Current opinion in urology · 2012 · 18 citations
    14. Recent advances in treatment for Benign Prostatic Hyperplasia F1000Research · 2015 · 12 citations
    15. Endocrine control of benign prostatic hyperplasia Andrology · 2016 · 97 citations
    16. The role of benign prostatic hyperplasia treatments in ejaculatory dysfunction Fertility and Sterility · 2021 · 8 citations
    17. Update on medical management of benign prostatic hyperplasia UK vet. Companion animal · 2008
    18. Medical Treatment of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia European urology. Supplement · 2009 · 10 citations
    19. Dihydrotestosterone and the Concept of 5α–Reductase Inhibition in Human Benign Prostatic Hyperplasia European Urology · 2000 · 184 citations
    20. Inhibitors of 5α-Reductase in the Treatment of Benign Prostatic Hyperplasia Current pharmaceutical design · 2006 · 52 citations
    21. Long-Term Experience With 5-alpha-Reductase Inhibitors. PubMed · 2003 · 6 citations
    22. 5α-Reductase Inhibitors and Chemoprevention: The PCPT and Beyond European Urology Supplements · 2006 · 2 citations
    23. Re: Can Long-Term LUTS/BPH Pharmacological Treatment Alter the Outcomes of Surgical Intervention? The Journal of Urology · 2017 · 1 citations
    24. Finasteride en de preventie van prostaatcarcinoom Medisch-Farmaceutische Mededelingen · 2004
    25. Clinical Pharmacokinetics and Pharmacodynamics of Finasteride Clinical Pharmacokinectics · 1996 · 93 citations
    26. Potency of a novel saw palmetto ethanol extract, SPET-085, for inhibition of 5α-reductase II Advances in Therapy · 2010 · 46 citations
    27. Maximum Efficacy of Finasteride Is Obtained within 6 Months and Maintained over 6 Years European Urology · 1998 · 34 citations
    28. ChemInform Abstract: Rα‐Reductase Inhibitors‐ — The Finasteride Story ChemInform · 2011
    29. New ester derivatives of dehydroepiandrosterone as 5α-reductase inhibitors Steroids · 2011 · 14 citations
    30. 황백(黃柏)이 전립선비대증(前立腺肥大症) Rat에 미치는 영향 Journal of Oriental Medicine · 2010